Antiplatelet therapy for Staphylococcus aureus bacteremia: Will it stick?
Staphylococcus aureus bacteremia (SAB) remains a clinically challenging infection despite extensive investigation. Repurposing medications approved for other indications is appealing as clinical safety profiles have already been established. Ticagrelor, a reversible adenosine diphosphate receptor an...
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Public Library of Science (PLoS)
2022-02-01
|
| Colecção: | PLoS Pathogens |
| Acesso em linha: | https://doi.org/10.1371/journal.ppat.1010240 |